0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Needle-Free Drug Delivery Systems Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-2W7182
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Needle Free Drug Delivery Systems Market Insights and Forecast to 2028
BUY CHAPTERS

Global Needle-Free Drug Delivery Systems Market Research Report 2025

Code: QYRE-Auto-2W7182
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Needle-Free Drug Delivery Systems Market Size

The global market for Needle-Free Drug Delivery Systems was valued at US$ 11320 million in the year 2024 and is projected to reach a revised size of US$ 19210 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Needle-Free Drug Delivery Systems Market

Needle-Free Drug Delivery Systems Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Needle-Free Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Drug Delivery Systems.
The Needle-Free Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Needle-Free Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Needle-Free Drug Delivery Systems Market Report

Report Metric Details
Report Name Needle-Free Drug Delivery Systems Market
Accounted market size in year US$ 11320 million
Forecasted market size in 2031 US$ 19210 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Jet-Based
  • Spring-Based
  • Laser-Based
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Antares Pharma, Pharmajet, Optinose, Valeritas, Crossject, Injex Pharma, 3M Pharmaceuticals, Becton Dickinson (BD), MedImmune, Mystic Pharmaceuticals, Zogenix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Needle-Free Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Needle-Free Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Needle-Free Drug Delivery Systems Market growing?

Ans: The Needle-Free Drug Delivery Systems Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Needle-Free Drug Delivery Systems Market size in 2031?

Ans: The Needle-Free Drug Delivery Systems Market size in 2031 will be US$ 19210 million.

Who are the main players in the Needle-Free Drug Delivery Systems Market report?

Ans: The main players in the Needle-Free Drug Delivery Systems Market are Antares Pharma, Pharmajet, Optinose, Valeritas, Crossject, Injex Pharma, 3M Pharmaceuticals, Becton Dickinson (BD), MedImmune, Mystic Pharmaceuticals, Zogenix

What are the Application segmentation covered in the Needle-Free Drug Delivery Systems Market report?

Ans: The Applications covered in the Needle-Free Drug Delivery Systems Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Needle-Free Drug Delivery Systems Market report?

Ans: The Types covered in the Needle-Free Drug Delivery Systems Market report are Jet-Based, Spring-Based, Laser-Based

Recommended Reports

Drug Delivery Systems

Needle-Free Technologies

Targeted & Advanced Delivery

1 Needle-Free Drug Delivery Systems Market Overview
1.1 Product Definition
1.2 Needle-Free Drug Delivery Systems by Type
1.2.1 Global Needle-Free Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Jet-Based
1.2.3 Spring-Based
1.2.4 Laser-Based
1.3 Needle-Free Drug Delivery Systems by Application
1.3.1 Global Needle-Free Drug Delivery Systems Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Needle-Free Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Needle-Free Drug Delivery Systems Revenue 2020-2031
1.4.2 Global Needle-Free Drug Delivery Systems Sales 2020-2031
1.4.3 Global Needle-Free Drug Delivery Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Needle-Free Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Needle-Free Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Needle-Free Drug Delivery Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Needle-Free Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Needle-Free Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Needle-Free Drug Delivery Systems, Product Type & Application
2.7 Global Key Manufacturers of Needle-Free Drug Delivery Systems, Date of Enter into This Industry
2.8 Global Needle-Free Drug Delivery Systems Market Competitive Situation and Trends
2.8.1 Global Needle-Free Drug Delivery Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Needle-Free Drug Delivery Systems Players Market Share by Revenue
2.8.3 Global Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Needle-Free Drug Delivery Systems Market Scenario by Region
3.1 Global Needle-Free Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Needle-Free Drug Delivery Systems Sales by Region: 2020-2031
3.2.1 Global Needle-Free Drug Delivery Systems Sales by Region: 2020-2025
3.2.2 Global Needle-Free Drug Delivery Systems Sales by Region: 2026-2031
3.3 Global Needle-Free Drug Delivery Systems Revenue by Region: 2020-2031
3.3.1 Global Needle-Free Drug Delivery Systems Revenue by Region: 2020-2025
3.3.2 Global Needle-Free Drug Delivery Systems Revenue by Region: 2026-2031
3.4 North America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Needle-Free Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Needle-Free Drug Delivery Systems Sales by Country (2020-2031)
3.4.3 North America Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Needle-Free Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Needle-Free Drug Delivery Systems Sales by Country (2020-2031)
3.5.3 Europe Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-Free Drug Delivery Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Needle-Free Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Needle-Free Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Needle-Free Drug Delivery Systems Sales by Country (2020-2031)
3.7.3 Latin America Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Needle-Free Drug Delivery Systems Sales by Type (2020-2031)
4.1.1 Global Needle-Free Drug Delivery Systems Sales by Type (2020-2025)
4.1.2 Global Needle-Free Drug Delivery Systems Sales by Type (2026-2031)
4.1.3 Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2031)
4.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2020-2031)
4.2.1 Global Needle-Free Drug Delivery Systems Revenue by Type (2020-2025)
4.2.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2026-2031)
4.2.3 Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2020-2031)
4.3 Global Needle-Free Drug Delivery Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Needle-Free Drug Delivery Systems Sales by Application (2020-2031)
5.1.1 Global Needle-Free Drug Delivery Systems Sales by Application (2020-2025)
5.1.2 Global Needle-Free Drug Delivery Systems Sales by Application (2026-2031)
5.1.3 Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2031)
5.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2020-2031)
5.2.1 Global Needle-Free Drug Delivery Systems Revenue by Application (2020-2025)
5.2.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2026-2031)
5.2.3 Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2020-2031)
5.3 Global Needle-Free Drug Delivery Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Antares Pharma
6.1.1 Antares Pharma Company Information
6.1.2 Antares Pharma Description and Business Overview
6.1.3 Antares Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Antares Pharma Needle-Free Drug Delivery Systems Product Portfolio
6.1.5 Antares Pharma Recent Developments/Updates
6.2 Pharmajet
6.2.1 Pharmajet Company Information
6.2.2 Pharmajet Description and Business Overview
6.2.3 Pharmajet Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pharmajet Needle-Free Drug Delivery Systems Product Portfolio
6.2.5 Pharmajet Recent Developments/Updates
6.3 Optinose
6.3.1 Optinose Company Information
6.3.2 Optinose Description and Business Overview
6.3.3 Optinose Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Optinose Needle-Free Drug Delivery Systems Product Portfolio
6.3.5 Optinose Recent Developments/Updates
6.4 Valeritas
6.4.1 Valeritas Company Information
6.4.2 Valeritas Description and Business Overview
6.4.3 Valeritas Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Valeritas Needle-Free Drug Delivery Systems Product Portfolio
6.4.5 Valeritas Recent Developments/Updates
6.5 Crossject
6.5.1 Crossject Company Information
6.5.2 Crossject Description and Business Overview
6.5.3 Crossject Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Crossject Needle-Free Drug Delivery Systems Product Portfolio
6.5.5 Crossject Recent Developments/Updates
6.6 Injex Pharma
6.6.1 Injex Pharma Company Information
6.6.2 Injex Pharma Description and Business Overview
6.6.3 Injex Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Injex Pharma Needle-Free Drug Delivery Systems Product Portfolio
6.6.5 Injex Pharma Recent Developments/Updates
6.7 3M Pharmaceuticals
6.7.1 3M Pharmaceuticals Company Information
6.7.2 3M Pharmaceuticals Description and Business Overview
6.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio
6.7.5 3M Pharmaceuticals Recent Developments/Updates
6.8 Becton Dickinson (BD)
6.8.1 Becton Dickinson (BD) Company Information
6.8.2 Becton Dickinson (BD) Description and Business Overview
6.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product Portfolio
6.8.5 Becton Dickinson (BD) Recent Developments/Updates
6.9 MedImmune
6.9.1 MedImmune Company Information
6.9.2 MedImmune Description and Business Overview
6.9.3 MedImmune Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 MedImmune Needle-Free Drug Delivery Systems Product Portfolio
6.9.5 MedImmune Recent Developments/Updates
6.10 Mystic Pharmaceuticals
6.10.1 Mystic Pharmaceuticals Company Information
6.10.2 Mystic Pharmaceuticals Description and Business Overview
6.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio
6.10.5 Mystic Pharmaceuticals Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Company Information
6.11.2 Zogenix Description and Business Overview
6.11.3 Zogenix Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zogenix Needle-Free Drug Delivery Systems Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-Free Drug Delivery Systems Industry Chain Analysis
7.2 Needle-Free Drug Delivery Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-Free Drug Delivery Systems Production Mode & Process Analysis
7.4 Needle-Free Drug Delivery Systems Sales and Marketing
7.4.1 Needle-Free Drug Delivery Systems Sales Channels
7.4.2 Needle-Free Drug Delivery Systems Distributors
7.5 Needle-Free Drug Delivery Systems Customer Analysis
8 Needle-Free Drug Delivery Systems Market Dynamics
8.1 Needle-Free Drug Delivery Systems Industry Trends
8.2 Needle-Free Drug Delivery Systems Market Drivers
8.3 Needle-Free Drug Delivery Systems Market Challenges
8.4 Needle-Free Drug Delivery Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Needle-Free Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Needle-Free Drug Delivery Systems Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Needle-Free Drug Delivery Systems Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Needle-Free Drug Delivery Systems Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Needle-Free Drug Delivery Systems Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Needle-Free Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Needle-Free Drug Delivery Systems, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Needle-Free Drug Delivery Systems, Product Type & Application
 Table 12. Global Key Manufacturers of Needle-Free Drug Delivery Systems, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Needle-Free Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Drug Delivery Systems as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Needle-Free Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Needle-Free Drug Delivery Systems Sales by Region (2020-2025) & (K Units)
 Table 18. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2020-2025)
 Table 19. Global Needle-Free Drug Delivery Systems Sales by Region (2026-2031) & (K Units)
 Table 20. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2026-2031)
 Table 21. Global Needle-Free Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2020-2025)
 Table 23. Global Needle-Free Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2026-2031)
 Table 25. North America Needle-Free Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Needle-Free Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 27. North America Needle-Free Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 28. North America Needle-Free Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Needle-Free Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Needle-Free Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Needle-Free Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Needle-Free Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Needle-Free Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Needle-Free Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Needle-Free Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Needle-Free Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Needle-Free Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Needle-Free Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Needle-Free Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Needle-Free Drug Delivery Systems Sales (K Units) by Type (2020-2025)
 Table 51. Global Needle-Free Drug Delivery Systems Sales (K Units) by Type (2026-2031)
 Table 52. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2020-2025)
 Table 53. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2026-2031)
 Table 54. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2020-2025)
 Table 57. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2026-2031)
 Table 58. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Needle-Free Drug Delivery Systems Sales (K Units) by Application (2020-2025)
 Table 61. Global Needle-Free Drug Delivery Systems Sales (K Units) by Application (2026-2031)
 Table 62. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2020-2025)
 Table 63. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2026-2031)
 Table 64. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2020-2025)
 Table 67. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2026-2031)
 Table 68. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2026-2031)
 Table 70. Antares Pharma Company Information
 Table 71. Antares Pharma Description and Business Overview
 Table 72. Antares Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Antares Pharma Needle-Free Drug Delivery Systems Product
 Table 74. Antares Pharma Recent Developments/Updates
 Table 75. Pharmajet Company Information
 Table 76. Pharmajet Description and Business Overview
 Table 77. Pharmajet Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Pharmajet Needle-Free Drug Delivery Systems Product
 Table 79. Pharmajet Recent Developments/Updates
 Table 80. Optinose Company Information
 Table 81. Optinose Description and Business Overview
 Table 82. Optinose Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Optinose Needle-Free Drug Delivery Systems Product
 Table 84. Optinose Recent Developments/Updates
 Table 85. Valeritas Company Information
 Table 86. Valeritas Description and Business Overview
 Table 87. Valeritas Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Valeritas Needle-Free Drug Delivery Systems Product
 Table 89. Valeritas Recent Developments/Updates
 Table 90. Crossject Company Information
 Table 91. Crossject Description and Business Overview
 Table 92. Crossject Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Crossject Needle-Free Drug Delivery Systems Product
 Table 94. Crossject Recent Developments/Updates
 Table 95. Injex Pharma Company Information
 Table 96. Injex Pharma Description and Business Overview
 Table 97. Injex Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Injex Pharma Needle-Free Drug Delivery Systems Product
 Table 99. Injex Pharma Recent Developments/Updates
 Table 100. 3M Pharmaceuticals Company Information
 Table 101. 3M Pharmaceuticals Description and Business Overview
 Table 102. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product
 Table 104. 3M Pharmaceuticals Recent Developments/Updates
 Table 105. Becton Dickinson (BD) Company Information
 Table 106. Becton Dickinson (BD) Description and Business Overview
 Table 107. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product
 Table 109. Becton Dickinson (BD) Recent Developments/Updates
 Table 110. MedImmune Company Information
 Table 111. MedImmune Description and Business Overview
 Table 112. MedImmune Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. MedImmune Needle-Free Drug Delivery Systems Product
 Table 114. MedImmune Recent Developments/Updates
 Table 115. Mystic Pharmaceuticals Company Information
 Table 116. Mystic Pharmaceuticals Description and Business Overview
 Table 117. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product
 Table 119. Mystic Pharmaceuticals Recent Developments/Updates
 Table 120. Zogenix Company Information
 Table 121. Zogenix Description and Business Overview
 Table 122. Zogenix Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Zogenix Needle-Free Drug Delivery Systems Product
 Table 124. Zogenix Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Needle-Free Drug Delivery Systems Distributors List
 Table 128. Needle-Free Drug Delivery Systems Customers List
 Table 129. Needle-Free Drug Delivery Systems Market Trends
 Table 130. Needle-Free Drug Delivery Systems Market Drivers
 Table 131. Needle-Free Drug Delivery Systems Market Challenges
 Table 132. Needle-Free Drug Delivery Systems Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Needle-Free Drug Delivery Systems
 Figure 2. Global Needle-Free Drug Delivery Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Needle-Free Drug Delivery Systems Market Share by Type: 2024 & 2031
 Figure 4. Jet-Based Product Picture
 Figure 5. Spring-Based Product Picture
 Figure 6. Laser-Based Product Picture
 Figure 7. Global Needle-Free Drug Delivery Systems Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Needle-Free Drug Delivery Systems Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Needle-Free Drug Delivery Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Needle-Free Drug Delivery Systems Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Needle-Free Drug Delivery Systems Sales (2020-2031) & (K Units)
 Figure 15. Global Needle-Free Drug Delivery Systems Average Price (USD/Unit) & (2020-2031)
 Figure 16. Needle-Free Drug Delivery Systems Report Years Considered
 Figure 17. Needle-Free Drug Delivery Systems Sales Share by Manufacturers in 2024
 Figure 18. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Needle-Free Drug Delivery Systems Players: Market Share by Revenue in Needle-Free Drug Delivery Systems in 2024
 Figure 20. Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Needle-Free Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 23. North America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 27. Europe Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Needle-Free Drug Delivery Systems Revenue Market Share by Region (2020-2031)
 Figure 35. China Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Needle-Free Drug Delivery Systems Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Needle-Free Drug Delivery Systems Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Needle-Free Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Needle-Free Drug Delivery Systems by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Needle-Free Drug Delivery Systems by Type (2020-2031)
 Figure 57. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Needle-Free Drug Delivery Systems by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Needle-Free Drug Delivery Systems by Application (2020-2031)
 Figure 60. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2020-2031)
 Figure 61. Needle-Free Drug Delivery Systems Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart